A plant-specific cyclin-dependent kinase is involved in the control of G2/M progression in plants

被引:133
|
作者
Porceddu, A
Stals, H
Reichheldt, JP
Segers, G
De Veylder, L
Barrôco, RD
Casteels, P
Van Montagu, M
Inzé, D
Mironov, V
机构
[1] Univ Ghent, Vakgrp Mol Genet, B-9000 Ghent, Belgium
[2] State Univ Ghent VIB, Dept Plantengenet, B-9000 Ghent, Belgium
关键词
D O I
10.1074/jbc.M011060200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclin-dependent kinases (CDKs) control the key transitions in the eukaryotic cell cycle. All the CDKs known to control G(2)/M progression in yeast and animals are distinguished by the characteristic PSTAIRE motif in their cyclin-binding domain and are closely related. Higher plants contain in addition a number of more divergent non-PSTAIRE CDKs with still obscure functions. We show that a plant-specific type of non-PSTAIRE CDKs is involved in the control of the G(2)/M progression. In synchronized tobacco BY-2 cells, the corresponding protein, accumulated in a cell cycle-regulated fashion, peaking at the G(2)/M transition. The associated histone HI kinase activity reached a maximum in mitosis and required a yet unidentified subunit to be fully active. Down-regulation of the associated kinase activity in transgenic tobacco plants using a dominant-negative mutation delayed G(2)/M transition. These results provide the first evidence that non-PSTAIRE CDKs are involved in the control of the G(2)/M progression in plants.
引用
收藏
页码:36354 / 36360
页数:7
相关论文
共 50 条
  • [41] Phosphorylation of cyclin O, a novel cyclin family protein containing a cyclin-like domain, is involved in the activation of cyclin-dependent kinase 2
    Kim, Do Hyung
    Park, Jong-Hwa
    Lee, Bora
    Jang, Kyoung Ok
    Chung, In Sik
    Han, Ye Sun
    ONCOLOGY LETTERS, 2014, 8 (06) : 2769 - 2775
  • [42] Antitumor imidazolyl disulfide IV-2 causes irreversible G2/M cell cycle arrest without hyperphosphorylation of cyclin-dependent kinase Cdk1
    Vogt, A
    Tamura, K
    Watson, S
    Lazo, JS
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 294 (03): : 1070 - 1075
  • [43] Inhibition of osteosarcoma cell progression by MacroH2A via the downregulation of cyclin D and cyclin-dependent kinase genes
    Yang, Pu
    Yin, Ke
    Zhong, Da
    Liao, Qiande
    Li, Kanghua
    MOLECULAR MEDICINE REPORTS, 2015, 11 (03) : 1905 - 1910
  • [44] Ubp-M serine 552 phosphorylation by cyclin-dependent kinase 1 regulates cell cycle progression
    Xu, Yang
    Yang, Huirong
    Joo, Heui-Yun
    Yu, Jei-Hwa
    Smith, Archer D.
    Schneider, David
    Chow, Louise T.
    Renfrow, Matthew
    Wang, Hengbin
    CELL CYCLE, 2013, 12 (19) : 3219 - 3227
  • [45] Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery
    Kimura, SH
    Ikawa, M
    Ito, A
    Okabe, M
    Nojima, H
    ONCOGENE, 2001, 20 (25) : 3290 - 3300
  • [46] Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery
    Shinya H Kimura
    Masahito Ikawa
    Akihiko Ito
    Masaru Okabe
    Hiroshi Nojima
    Oncogene, 2001, 20 : 3290 - 3300
  • [47] INCREASED AND ALTERED DNA-BINDING OF HUMAN P53 BY S AND G2/M BUT NOT G1 CYCLIN-DEPENDENT KINASES
    WANG, Y
    PRIVES, C
    NATURE, 1995, 376 (6535) : 88 - 91
  • [48] Cardiac-specific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes
    Liao, HS
    Kang, PM
    Nagashima, H
    Yamasaki, N
    Usheva, A
    Ding, B
    Lorell, BH
    Izumo, S
    CIRCULATION RESEARCH, 2001, 88 (04) : 443 - 450
  • [49] Cyclin-dependent kinase regulates the repair mode of non-homologous end joining during S/G2 phase in budding yeast
    Terasawa, Masahiro
    Matsuzaki, Kenichiro
    Shinohara, Miki
    GENES & GENETIC SYSTEMS, 2011, 86 (06) : 433 - 433
  • [50] Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells
    S M Manohar
    A A Padgaonkar
    A Jalota-Badhwar
    S V Rao
    K S Joshi
    Prostate Cancer and Prostatic Diseases, 2012, 15 : 15 - 27